Communiqués DexCom, Inc.

Actions

DXCM

US2521311074

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 05/08/2026			Pré-ouverture 15:29:04
82,66 ^USD	-4,92 %		83,04	+0,47 %

04/08	DEXCOM, INC. : Argus persiste à l'achat	ZM
03/08	DEXCOM, INC. : UBS persiste à l'achat	ZM

Communiqués

30/07	DexCom: Q2 Earnings Snapshot	AQ
30/07	Dexcom Reports Second Quarter 2026 Financial Results	BU
22/07	Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program	BU
13/07	Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes	PU
13/07	LE DEXCOM G7 15 JOURS A OBTENU L’AUTORISATION DE SANTÉ CANADA : UNE DURÉE DE PORT PROLONGÉE ET UNE CONTINUITÉ AMÉLIORÉE POUR LES ADULTES CANADIENS VIVANT AVEC LE DIABÈTE	BU
09/07	Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time	BU
03/07	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
23/06	Dexcom Further Advances Vision of Glucose Biosensing for All	BU
06/06	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin	BU
04/06	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026	BU
02/06	Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience	BU
26/05	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users	BU
19/05	DexCom : Operations and Innovation Committee	PU
18/05	Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany	BU
14/05	Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day	BU
06/05	DexCom : Trade Association Report 2025	PU
05/05	Dexcom to Host Investor Day on May 14, 2026	BU
30/04	DexCom: Q1 Earnings Snapshot	AQ
30/04	Dexcom Reports First Quarter 2026 Financial Results	BU
29/04	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics	AQ
10/04	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
02/04	Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time	BU
11/03	Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026	BU
26/02	Dexcom Appoints Rick Osterloh to Board of Directors	BU
26/02	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR